HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Miguel Angel Piris Selected Research

Miguel Angel Piris Research Topics

Disease

11Neoplasms (Cancer)
03/2023 - 04/2005
6Lymphoma (Lymphomas)
01/2019 - 06/2005
3Leukemia
05/2020 - 06/2005
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2017 - 06/2005
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2014 - 07/2007
2Burkitt Lymphoma (Burkitt's Lymphoma)
01/2014 - 06/2011
1Pancytopenia
03/2023
1Hemolysis
03/2023
1Multiple Myeloma
01/2023
1Hodgkin Disease (Hodgkin's Disease)
01/2021
1Graft vs Host Disease (Graft-Versus-Host Disease)
05/2020
1Drug Eruptions (Drug Eruption)
05/2020
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2019
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2017
1Hyperplasia
12/2014
1Carcinogenesis
06/2006
1Hypoxia (Hypoxemia)
06/2006
1Neoplasm Metastasis (Metastasis)
04/2006
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2005
1Hematologic Neoplasms (Hematological Malignancy)
06/2005

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
01/2013 - 04/2006
2Immunoglobulins (Immunoglobulin)IBA
01/2023 - 04/2016
2AntigensIBA
01/2019 - 04/2016
2MicroRNAs (MicroRNA)IBA
01/2014 - 06/2011
2DNA (Deoxyribonucleic Acid)IBA
03/2009 - 04/2005
1Adrenal Cortex Hormones (Corticosteroids)IBA
03/2023
1AgglutininsIBA
03/2023
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2023
1Immunoglobulin M (IgM)IBA
03/2023
1Rituximab (Mabthera)FDA Link
03/2023
1ibrutinibIBA
03/2023
1ATPases Associated with Diverse Cellular ActivitiesIBA
01/2023
1Proteasome InhibitorsIBA
01/2023
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2023
1CollagenIBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Complementarity Determining Regions (Complementarity Determining Region)IBA
01/2019
1Cyclin D3IBA
01/2017
1GuanineIBA
01/2017
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
12/2014
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2014
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
06/2006
19,10-Dimethyl-1,2-benzanthraceneIBA
06/2006
1NF-kappa B (NF-kB)IBA
06/2006
1Complementary DNA (cDNA)IBA
06/2006
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
06/2006
1Poly(ADP-ribose) Polymerase InhibitorsIBA
06/2006
1CeramidesIBA
04/2006
1CannabinoidsIBA
04/2006
1Lamin Type A (Lamin A)IBA
06/2005
1hydrogen sulfite (bisulfite)IBA
06/2005
1LaminsIBA
06/2005
1Histones (Histone)IBA
04/2005

Therapy/Procedure

4Therapeutics
01/2017 - 07/2007
1Transplantation
05/2020
1Drug Therapy (Chemotherapy)
05/2020